Stopped: This clinical trial was terminated on June 7, 2024 due to new information about contraindications of using the study drug in this population.
Hyperglycemia is seen in approximately 30% of patients who do not have a history of diabetes and undergo general surgery. Hyperglycemia in this setting is associated with increased risk of postoperative complications. The purpose of this study is to investigate risk factors for developing high sugars during the time of surgery, and if these high sugars can be prevented by the use of an injectable diabetes medication (dulaglutide) prior to surgery.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Percentage of Time in Target Glucose Range (70-140 mg/dL) by CGM
Timeframe: During hospitalization (up to 5 days postoperatively)